Cargando…

Influential Factors and Efficacy Analysis of Tacrolimus Concentration After Allogeneic Hematopoietic Stem Cell Transplantation in Children with β-Thalassemia Major

PURPOSE: To analyze factors influencing tacrolimus (TAC) trough concentration (C(0)) in β-thalassemia major (β-TM) pediatric patients after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and to investigate the effects of genotype polymorphism and drug-drug interactions on TAC trough...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chengxin, Lu, Jiejiu, Zhou, Siru, Wei, Yinyi, Lv, Chunle, Liu, Taotao, Wu, Yun, Wu, Dongni, Qi, Jianying, Cai, Rongda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478485/ https://www.ncbi.nlm.nih.gov/pubmed/34594128 http://dx.doi.org/10.2147/PGPM.S325103

Ejemplares similares

Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation
por: Wei, Yinyi, et al.
Publicado: (2022)

Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients
por: Zhu, Jing, et al.
Publicado: (2020)

Hepatic veno-occlusive disease resulting in tacrolimus toxicity after allogeneic hematopoietic stem cell transplantation
por: Shin, Seung-Hwan, et al.
Publicado: (2013)

Elevation of tacrolimus concentration after administration of methotrexate for treatment of graft-versus-host disease in pediatric patients received allogeneic hematopoietic stem cell transplantation
por: Inoue, Chiaki, et al.
Publicado: (2023)

Survival and late effects of hematopoietic cell transplantation in patients with thalassemia major
por: Santarone, Stella, et al.
Publicado: (2022)

Relationship between CYP3A5 Polymorphism and Tacrolimus Blood Concentration Changes in Allogeneic Hematopoietic Stem Cell Transplant Recipients during Continuous Infusion
por: Yoshikawa, Naoki, et al.
Publicado: (2021)

Impact of CYP3A5, POR, and CYP2C19 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplantation
por: Suetsugu, Kimitaka, et al.
Publicado: (2019)

Possible Tacrolimus-Related Neuropsychiatric Symptoms: One Year After Allogeneic Hematopoietic Cell Transplantation: A Case Report
por: Løhde, Linda W, et al.
Publicado: (2022)

Case report: First report of haploidentical allogeneic hematopoietic stem cell transplantation from donors with mild alpha-thalassemia for acute leukemia
por: Zheng, Wenshuai, et al.
Publicado: (2022)

Effect of Hypertransfusion on Extramedullary Hematopoietic Compression Mass in Thalassemia Major: A Case Report
por: Emamhadi, Mohammadreza, et al.
Publicado: (2012)

Hematopoietic stem cell transplantation for children with β-thalassemia major: multicenter experience in China
por: Li, Xin-Yu, et al.
Publicado: (2018)

MRI Evaluation of Liver Iron Concentration in Patients with β-Thalassemia Major
por: Karimi, M, et al.
Publicado: (2010)

A Study of Leptin Serum Concentrations in Patients with Major Beta-Thalassemia
por: Shahramian, I, et al.
Publicado: (2013)

Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors
por: Perez, Lia Elena, et al.
Publicado: (2016)

Hematopoietic Stem Cell Transplantation and Results in Pediatric Patients with Thalassemia Major: Single-Center Study
por: Ayçiçek, Ali, et al.
Publicado: (2022)

Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
por: DeFilipp, Zachariah, et al.
Publicado: (2019)

Epidemiology and treatment of beta thalassemia major in China
por: Xu, Xiaoxiao, et al.
Publicado: (2019)

Effective method of evaluating myocardial iron concentration in pediatric patients with thalassemia major
por: Khaled, Arwa, et al.
Publicado: (2019)

Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients
por: Zhu, Jing, et al.
Publicado: (2021)

Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience
por: Rahal, Ilhem, et al.
Publicado: (2018)

Hematopoietic stem cell transplantation for thalassemia major using HLA fully-matched and mismatched donor grafts
por: Huang, Chuwen, et al.
Publicado: (2021)

Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
por: Sharma, Nidhi, et al.
Publicado: (2021)

Endocrinopathies in Thalassemia major patients in Thalassemia Center Jakarta, Indonesia
por: Soesanti, Frida, et al.
Publicado: (2013)

Variations in postoperative electrolyte concentrations and influential factors in hip arthroscopy
por: Gao, Guanying, et al.
Publicado: (2022)

Thalassemia Major: The Present and the Future
por: Baldini, Marina
Publicado: (2012)

Hypogonadism in thalassemia major patients
por: Srisukh, Sasima, et al.
Publicado: (2016)

Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome
por: Lai, Xiaoxuan, et al.
Publicado: (2021)

Successful Treatment of Behçet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation
por: Nakamura, Yukinori, et al.
Publicado: (2017)

Development and effects of tacrolimus-loaded nanoparticles on the inhibition of corneal allograft rejection
por: Wu, Qianni, et al.
Publicado: (2019)

Career choice and influential factors among medical students majoring in psychiatry in China
por: Zhang, Ying-Jian, et al.
Publicado: (2021)

Tacrolimus Concentration after Letermovir Initiation in Hematopoietic Stem Cell Transplantation Recipients Receiving Voriconazole: A Retrospective, Observational Study
por: Hikasa, Shinichi, et al.
Publicado: (2020)

Quality of life in patients with thalassemia major
por: Ansari, Sh, et al.
Publicado: (2014)

Knowledge, Attitude and Practice of Carrier Thalassemia Marriage Volunteer in Prevention of Major Thalassemia
por: Karimzaei, Tahmineh, et al.
Publicado: (2015)

Serum Lipids in Turkish Patients with β-Thalassemia Major and β-Thalassemia Minor
por: Işık Balcı, Yasemin, et al.
Publicado: (2016)

Detection of Extramedullary Hematopoietic Tissue in a Patient with Beta-Thalassemia Major on Tc99m-Sestamibi Parathyroid Scintigraphy
por: Valotassiou, Varvara, et al.
Publicado: (2019)

Returning to employment following allogeneic hematopoietic stem cell transplant: A major problem among survivors
por: Filgueira, Luis, et al.
Publicado: (2023)

Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation
por: Wu, Yibo, et al.
Publicado: (2021)

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go
por: Lv, Meng, et al.
Publicado: (2012)

Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation
por: Du, Wei, et al.
Publicado: (2018)

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b9qk68ljo0to6bnrtvhnc5svad